Biblio
Export 140 results:
[ Author
Filters: First Letter Of Last Name is T [Clear All Filters]
“Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
, “The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples.”, J Alzheimers Dis, vol. 64, no. 2, pp. 643-655, 2018.
, “Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?”, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
, “Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life.”, J Alzheimers Dis, vol. 69, no. 3, pp. 817-827, 2019.
, “Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population.”, J Alzheimers Dis, vol. 60, no. 1, pp. 69-86, 2017.
, “Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.”, J Alzheimers Dis, vol. 56, no. 2, pp. 585-599, 2017.
, “Automatic Subtyping of Individuals with Primary Progressive Aphasia.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1185-1194, 2021.
, “Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
, “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
, “Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1857-1863, 2018.
, “Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1713-1724, 2018.
, “Remembering Robert D. Terry at a Time of Change in the World of Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 3, pp. 621-628, 2019.
, “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
, “Association of Interleukin-6 and Interleukin-8 with Cognitive Decline in an Asian Memory Clinic Population.”, J Alzheimers Dis, vol. 92, no. 2, pp. 445-455, 2023.
, “The Price of Stress: High Bedtime Salivary Cortisol Levels Are Associated with Brain Atrophy and Cognitive Decline in Stroke Survivors. Results from the TABASCO Prospective Cohort Study.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1365-1375, 2018.
, “A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1065-1074, 2017.
, “Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S497-S505, 2018.
, “Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 801-813, 2018.
, “Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1443-51, 2016.
, “Hippocampus and Basal Forebrain Volumetry for Dementia and Mild Cognitive Impairment Diagnosis: Could It Be Useful in Primary Care?”, J Alzheimers Dis, vol. 55, no. 4, pp. 1379-1394, 2017.
, “Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1267-1282, 2022.
, “Informal Caregivers' Attitude Toward Dementia: The Impact of Dementia Knowledge, Confidence in Dementia Care, and the Behavioral and Psychological Symptoms of the Person with Dementia. A Cross-Sectional Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 971-984, 2022.
, “PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
, “Olfactory Function is Associated with Cognitive Performance: Results of the Heinz Nixdorf Recall Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 319-329, 2018.
, “Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial.”, J Alzheimers Dis, vol. 71, no. 2, pp. 421-433, 2019.
,